| International Working Group consensus response evaluation criteria in lymphoma (RECIL 2017) A Younes, P Hilden, B Coiffier, A Hagenbeek, G Salles, W Wilson, ... Annals of Oncology 28 (7), 1436-1447, 2017 | 339 | 2017 |
| A phase 2 trial of stereotactic radiosurgery boost after surgical resection for brain metastases C Brennan, TJ Yang, P Hilden, Z Zhang, K Chan, Y Yamada, TA Chan, ... International Journal of Radiation Oncology* Biology* Physics 88 (1), 130-136, 2014 | 240 | 2014 |
| Prognostic value of FDG-PET prior to autologous stem cell transplantation for relapsed and refractory diffuse large B-cell lymphoma CS Sauter, MJ Matasar, J Meikle, H Schoder, GA Ulaner, JC Migliacci, ... Blood, The Journal of the American Society of Hematology 125 (16), 2579-2581, 2015 | 146 | 2015 |
| High day 28 ST2 levels predict for acute graft-versus-host disease and transplant-related mortality after cord blood transplantation DM Ponce, P Hilden, C Mumaw, SM Devlin, M Lubin, S Giralt, ... Blood, The Journal of the American Society of Hematology 125 (1), 199-205, 2015 | 122 | 2015 |
| A phase 2 single-center study of carfilzomib 56 mg/m2 with or without low-dose dexamethasone in relapsed multiple myeloma N Lendvai, P Hilden, S Devlin, H Landau, H Hassoun, AM Lesokhin, ... Blood, The Journal of the American Society of Hematology 124 (6), 899-906, 2014 | 90 | 2014 |
| Allogeneic haematopoietic cell transplantation impacts on outcomes of mantle cell lymphoma with TP53 alterations RJ Lin, C Ho, PD Hilden, JN Barker, SA Giralt, PA Hamlin, AA Jakubowski, ... British journal of haematology 184 (6), 1006-1010, 2019 | 64 | 2019 |
| Improved outcomes with an enhanced recovery approach to cesarean delivery L Mullman, P Hilden, J Goral, N Gwacham, C Tauro, K Spinola, K Rosales, ... Obstetrics & Gynecology 136 (4), 685-691, 2020 | 63 | 2020 |
| CD34-selected hematopoietic stem cell transplants conditioned with myeloablative regimens and antithymocyte globulin for advanced myelodysplastic syndrome: limited graft-versus … R Tamari, SS Chung, EB Papadopoulos, AA Jakubowski, P Hilden, ... Biology of Blood and Marrow Transplantation 21 (12), 2106-2114, 2015 | 57 | 2015 |
| High disease-free survival with enhanced protection against relapse after double-unit cord blood transplantation when compared with T cell–depleted unrelated donor … DM Ponce, P Hilden, SM Devlin, M Maloy, M Lubin, H Castro-Malaspina, ... Biology of Blood and Marrow Transplantation 21 (11), 1985-1993, 2015 | 49 | 2015 |
| Ex Vivo CD34+–Selected T Cell–Depleted Peripheral Blood Stem Cell Grafts for Allogeneic Hematopoietic Stem Cell Transplantation in Acute Leukemia and Myelodysplastic Syndrome … P Barba, P Hilden, SM Devlin, M Maloy, D Dierov, J Nieves, MD Garrett, ... Biology of blood and marrow transplantation 23 (3), 452-458, 2017 | 48 | 2017 |
| Intensified mycophenolate mofetil dosing and higher mycophenolic acid trough levels reduce severe acute graft-versus-host disease after double-unit cord blood transplantation S Harnicar, DM Ponce, P Hilden, J Zheng, SM Devlin, M Lubin, ... Biology of Blood and Marrow Transplantation 21 (5), 920-925, 2015 | 46 | 2015 |
| Comparison of outcomes at two institutions of patients with ALL receiving ex vivo T-cell-depleted or unmodified allografts GS Hobbs, A Hamdi, PD Hilden, JD Goldberg, ML Poon, C Ledesma, ... Bone marrow transplantation 50 (4), 493-498, 2015 | 43 | 2015 |
| Radiation dose and volume to the pancreas and subsequent risk of diabetes mellitus: a report from the childhood cancer survivor study DN Friedman, CS Moskowitz, P Hilden, RM Howell, RE Weathers, ... JNCI: Journal of the National Cancer Institute 112 (5), 525-532, 2020 | 41 | 2020 |
| Cardiovascular risk factors in survivors of childhood hematopoietic cell transplantation treated with total body irradiation: a longitudinal analysis DN Friedman, P Hilden, CS Moskowitz, M Suzuki, F Boulad, NA Kernan, ... Biology of Blood and Marrow Transplantation 23 (3), 475-482, 2017 | 39 | 2017 |
| Robust CD4+ T-cell recovery in adults transplanted with cord blood and no antithymocyte globulin I Politikos, JA Lavery, P Hilden, C Cho, T Borrill, MA Maloy, SA Giralt, ... Blood Advances 4 (1), 191-202, 2020 | 38 | 2020 |
| Big data, machine learning, and artificial intelligence: a field guide for neurosurgeons B Raju, F Jumah, O Ashraf, V Narayan, G Gupta, H Sun, P Hilden, ... Journal of neurosurgery 1 (aop), 1-11, 2020 | 37 | 2020 |
| BET inhibition-induced GSK3β feedback enhances lymphoma vulnerability to PI3K inhibitors E Derenzini, P Mondello, T Erazo, A Portelinha, Y Liu, M Scallion, ... Cell reports 24 (8), 2155-2166, 2018 | 35 | 2018 |
| A comparative analysis of long-term survival of robotic versus thoracoscopic lobectomy J Sesti, RC Langan, J Bell, A Nguyen, AL Turner, P Hilden, K Leshchuk, ... The Annals of Thoracic Surgery 110 (4), 1139-1146, 2020 | 32 | 2020 |
| Integrated DNA/RNA targeted genomic profiling of diffuse large B-cell lymphoma using a clinical assay AM Intlekofer, E Joffe, CL Batlevi, P Hilden, J He, VE Seshan, AD Zelenetz, ... Blood cancer journal 8 (6), 60, 2018 | 32 | 2018 |
| Burden and impact of multifactorial geriatric syndromes in allogeneic hematopoietic cell transplantation for older adults RJ Lin, PD Hilden, TA Elko, PB Dahi, A Shahrokni, AA Jakubowski, ... Blood Advances 3 (1), 12-20, 2019 | 31 | 2019 |
